Press Resease

Veterinary Molecular Diagnostics Market by Technology (Microarrays, Polymerase Chain Reaction (PCR), and DNA Sequencing), by Animal Type (Livestock Animals and Companion Animals), by Disease Indication (Diarrhea Pathogens Detection, Vector-borne Diseases, Respiratory Pathogens Detection, and Others), by Product (Kits & Reagents, Instruments & Software, and Services), and End User (Research Institutes, Clinical Laboratories, and Veterinary Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 09-Jul-2018 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3205 Status : Published

Global veterinary molecular diagnostics market expected to reach USD 736.2 million by 2024, growing at a CAGR of around 8.7% between 2018 and 2024. Veterinary molecular diagnostics market is segmented on the basis of product which is further divided into three types: instruments & software, kits & reagents, and services.

Description

The report covers forecast and analysis for the veterinary molecular diagnostics market on a global and regional level. The study provides historical data from 2017 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the veterinary molecular diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the veterinary molecular diagnostics market on a global level.

In order to give the users of this report a comprehensive view on the veterinary molecular diagnostics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment, technology segment, animal type segment, disease indication segment, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Veterinary Molecular Diagnostics Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view on the veterinary molecular diagnostics market by segmenting the market based on technology veterinary molecular diagnostics market has been segmented into microarrays, polymerase chain reaction (PCR), and DNA sequencing. On the basis of the animal type, the market for veterinary molecular diagnostics is segmented into livestock animals and companion animals. Based on disease indication the veterinary molecular diagnostics market has been segmented into diarrhea pathogens detection, vector-borne diseases, respiratory pathogens detection, and others. Segmentation based on a product for veterinary molecular diagnostics includes kits & reagents, instruments & software, and services. The end-user segment for veterinary molecular diagnostics is divided into research institutes, clinical laboratories, and veterinary hospitals. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, U.K., Germany, France, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Argentina, Saudi Arabia, UAE, Qatar, and South Africa. This segmentation includes demand for veterinary molecular diagnostics market based on technology, animal type, disease indication product, and end-user in all the regions and countries.

The report also includes detailed profiles of end players such as IDEXX Laboratories, Inc., ABAXIS, Inc., VCA, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Zoetis, Inc., GE Healthcare, Heska Corporation, ID.Vet, Virbac, Veterinary Molecular Diagnostics, Inc., and AGFA Healthcare.

This report segments the global veterinary molecular diagnostics market as follows:

Global Veterinary Molecular Diagnostics Market: Product Segment Analysis

  • Instruments & Software
  • Kits & Reagents 
  • Services

Global Veterinary Molecular Diagnostics Market: Technology Segment Analysis

  • Polymerase Chain Reaction (PCR)
  • Microarrays
  • DNA Sequencing

Global Veterinary Molecular Diagnostics Market: Animal Type Segment Analysis

  • Companion Animals 
  • Livestock Animals

Global Veterinary Molecular Diagnostics Market: Disease Indication Segment Analysis

  • Vector-borne Diseases
  • Respiratory Pathogens Detection
  • Diarrhea Pathogens Detection
  • Others

Global Veterinary Molecular Diagnostics Market: End-User Segment Analysis

  • Veterinary Hospitals
  • Clinical Laboratories
  • Research Institutes

Global Veterinary Molecular Diagnostics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Veterinary Molecular Diagnostics Market, 2017 - 2024 (USD Million)
    • 2.2. Global Veterinary Molecular Diagnostics Market: Snapshot
  •  
  • Chapter 3. Veterinary Molecular Diagnostics Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Veterinary Molecular Diagnostics market drivers: Impact analysis
      • 3.2.2. Emergence of advanced veterinary molecular diagnostic tools over traditional diagnostic.
      • 3.2.3. Growing focus on adopted pet's and livestock's health and nutrition
    • 3.3. Market Restraints
      • 3.3.1. Global Veterinary Molecular Diagnostics market restraints: Impact analysis
      • 3.3.2. High costs associated with these techniques
    • 3.4. Opportunities
      • 3.4.1. Revealing new diseases and facts of existing diseases
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by technology segment
      • 3.6.3. Market attractiveness analysis, by animal type segment
      • 3.6.4. Market attractiveness analysis, by disease indication segment
      • 3.6.5. Market attractiveness analysis, by end user segment
      • 3.6.6. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Veterinary Molecular Diagnostics Market- Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Veterinary Molecular Diagnostics market: company market share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapy Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
    • 4.3. Price Trend Analysis
  •  
  • Chapter 5. Global Veterinary Molecular Diagnostics Market- Product Segment Analysis
    • 5.1. Global Veterinary Molecular Diagnostics market: product overview
      • 5.1.1. Global Veterinary Molecular Diagnostics market revenue share, by product, 2018 and 2024
    • 5.2. Instruments & Software
      • 5.2.1. Global Veterinary Molecular Diagnostics market for instruments & software market, 2018 - 2024 (USD Million)
    • 5.3. Kits & Reagents
      • 5.3.1. Global Veterinary Molecular Diagnostics market for kits & reagents market, 2018 - 2024 (USD Million)
    • 5.4. Services
      • 5.4.1. Global Veterinary Molecular Diagnostics market for services market, 2018 - 2024 (USD Million)
  •  
  • Chapter 6. Global Veterinary Molecular Diagnostics Market- Technology Segment Analysis
    • 6.1. Global Veterinary Molecular Diagnostics market: Technology overview
      • 6.1.1. Global Veterinary Molecular Diagnostics market revenue share, by technology, 2018 and 2024
    • 6.2. Polymerase Chain Reaction (PCR)
      • 6.2.1. Global Veterinary Molecular Diagnostics market for Polymerase Chain Reaction (PCR) market, 2017 - 2024 (USD Million)
    • 6.3. Microarrays
      • 6.3.1. Global Veterinary Molecular Diagnostics market for microarrays market, 2017 - 2024 (USD Million)
    • 6.4. DNA Sequencing
      • 6.4.1. Global Veterinary Molecular Diagnostics market for DNA sequencing market, 2017 - 2024 (USD Million)
  •  
  • Chapter 7. Global Veterinary Molecular Diagnostics Market- Animal Type Segment Analysis
    • 7.1. Global Veterinary Molecular Diagnostics market: Animal Type overview
      • 7.1.1. Global Veterinary Molecular Diagnostics market revenue share, by Animal Type, 2017 and 2024
    • 7.2. Companion Animals
      • 7.2.1. Global Veterinary Molecular Diagnostics market for companion animals 2017 - 2024 (USD Million)
    • 7.3. Livestock Animals
      • 7.3.1. Global Veterinary Molecular Diagnostics market for livestock animals, 2017 - 2024 (USD Million)
  •  
  • Chapter 8. Global Veterinary Molecular Diagnostics Market- Disease Indication Segment Analysis
    • 8.1. Global Veterinary Molecular Diagnostics market: Disease Indication overview
      • 8.1.1. Global Veterinary Molecular Diagnostics market revenue share, by Disease Indication, 2017 and 2024
    • 8.2. Vector-borne Diseases
      • 8.2.1. Global Veterinary Molecular Diagnostics market for vector-borne diseases 2017 - 2024 (USD Million)
    • 8.3. Respiratory Pathogens Detection
      • 8.3.1. Global Veterinary Molecular Diagnostics market for respiratory pathogens detection, 2017 - 2024 (USD Million)
    • 8.4. Diarrhea Pathogens Detection
      • 8.4.1. Global Veterinary Molecular Diagnostics market for diarrhea pathogens detection, 2017 - 2024 (USD Million)
    • 8.5. Other
      • 8.5.1. Global Veterinary Molecular Diagnostics market for other, 2017 - 2024 (USD Million)
  •  
  • Chapter 9. Global Veterinary Molecular Diagnostics Market- End User Segment Analysis
    • 9.1. Global Veterinary Molecular Diagnostics market: End User overview
      • 9.1.1. Global Veterinary Molecular Diagnostics market revenue share, by End User, 2017 and 2024
    • 9.2. Veterinary Hospitals
      • 9.2.1. Global Veterinary Molecular Diagnostics market for veterinary hospitals 2017 - 2024 (USD Million)
    • 9.3. Clinical Laboratories
      • 9.3.1. Global Veterinary Molecular Diagnostics market for clinical laboratories, 2017 - 2024 (USD Million)
    • 9.4. Research Institutes
      • 9.4.1. Global Veterinary Molecular Diagnostics market for research institutes, 2017 - 2024 (USD Million)
  •  
  • Chapter 10. Global Veterinary Molecular Diagnostics Market- Regional Segment Analysis
    • 10.1. Global Veterinary Molecular Diagnostics market: regional overview
      • 10.1.1. Global Veterinary Molecular Diagnostics market revenue share, by region, 2017 and 2024
    • 10.2. North America
      • 10.2.1. North America Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
      • 10.2.2. North America Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
      • 10.2.3. North America Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
      • 10.2.4. North America Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
      • 10.2.5. North America Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.2.6. U.S.
        • 10.2.6.1. U.S. Veterinary Molecular Diagnostics market product, by therapy type, 2017 - 2024 (USD Million)
        • 10.2.6.2. U.S. Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.2.6.3. U.S. Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.2.6.4. U.S. Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.2.6.5. U.S. Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.2.7. Canada
        • 10.2.7.1. Canada Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.2.7.2. Canada Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.2.7.3. Canada Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.2.7.4. Canada Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.2.7.5. Canada Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.2.8. Rest of North America
        • 10.2.8.1. Rest of North America Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.2.8.2. Rest of North America Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.2.8.3. Rest of North America Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.2.8.4. Rest of North America Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.2.8.5. Rest of North America Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
    • 10.3. Europe
      • 10.3.1. Europe Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
      • 10.3.2. Europe Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
      • 10.3.3. Europe Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
      • 10.3.4. Europe Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
      • 10.3.5. Europe Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.3.6. U.K.
        • 10.3.6.1. U.K. Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.3.6.2. U.K. Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.3.6.3. U.K. Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.3.6.4. U.K. Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.3.6.5. U.K. Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.3.7. Germany
        • 10.3.7.1. Germany Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.3.7.2. Germany Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.3.7.3. Germany Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.3.7.4. Germany Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.3.7.5. Germany Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.3.8. France
        • 10.3.8.1. France Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.3.8.2. France Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.3.8.3. France Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.3.8.4. France Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.3.8.5. France Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.3.9. Italy
        • 10.3.9.1. Italy Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.3.9.2. Italy Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.3.9.3. Italy Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.3.9.4. Italy Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.3.9.5. Italy Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.3.10. Spain
        • 10.3.10.1. Spain Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.3.10.2. Spain Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.3.10.3. Spain Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.3.10.4. Spain Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.3.10.5. Spain Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.3.11. Russia
        • 10.3.11.1. Russia Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.3.11.2. Russia Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.3.11.3. Russia Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.3.11.4. Russia Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.3.11.5. Russia Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.3.12. Rest of Europe
        • 10.3.12.1. Rest of Europe Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.3.12.2. Rest of Europe Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.3.12.3. Rest of Europe Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.3.12.4. Rest of Europe Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.3.12.5. Rest of Europe Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
      • 10.4.2. Asia Pacific Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
      • 10.4.3. Asia Pacific Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
      • 10.4.4. Asia Pacific Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
      • 10.4.5. Asia Pacific Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.4.6. China
        • 10.4.6.1. China Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.4.6.2. China Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.4.6.3. China Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.4.6.4. China Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.4.6.5. China Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.4.7. Japan
        • 10.4.7.1. Japan Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.4.7.2. Japan Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.4.7.3. Japan Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.4.7.4. Japan Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.4.7.5. Japan Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.4.8. India
        • 10.4.8.1. India Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.4.8.2. India Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.4.8.3. India Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.4.8.4. India Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.4.8.5. India Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.4.9. Australia
        • 10.4.9.1. Australia Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.4.9.2. Australia Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.4.9.3. Australia Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.4.9.4. Australia Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.4.9.5. Australia Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.4.10. Rest of Asia Pacific
        • 10.4.10.1. Rest of Asia Pacific Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.4.10.2. Rest of Asia Pacific Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.4.10.3. Rest of Asia Pacific Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.4.10.4. Rest of Asia Pacific Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.4.10.5. Rest of Asia Pacific Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
    • 10.5. Latin America
      • 10.5.1. Latin America Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
      • 10.5.2. Latin America Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
      • 10.5.3. Latin America Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
      • 10.5.4. Latin America Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
      • 10.5.5. Latin America Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.5.6. Brazil
        • 10.5.6.1. Brazil Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.5.6.2. Brazil Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.5.6.3. Brazil Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.5.6.4. Brazil Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.5.6.5. Brazil Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.5.7. Mexico
        • 10.5.7.1. Mexico Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.5.7.2. Mexico Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.5.7.3. Mexico Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.5.7.4. Mexico Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.5.7.5. Mexico Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.5.8. Argentina
        • 10.5.8.1. Argentina Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.5.8.2. Argentina Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.5.8.3. Argentina Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.5.8.4. Argentina Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.5.8.5. Argentina Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.5.9. Rest of Latin America
        • 10.5.9.1. Rest of Latin America Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.5.9.2. Rest of Latin America Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.5.9.3. Rest of Latin America Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.5.9.4. Rest of Latin America Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.5.9.5. Rest of Latin America Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
    • 10.6. Middle East and Africa
      • 10.6.1. Middle East & Africa Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
      • 10.6.2. Middle East & Africa Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
      • 10.6.3. Middle East & Africa Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
      • 10.6.4. Middle East & Africa Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
      • 10.6.5. Middle East & Africa Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.6.6. Saudi Arabia
        • 10.6.6.1. Saudi Arabia Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.6.6.2. Saudi Arabia Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.6.6.3. Saudi Arabia Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.6.6.4. Saudi Arabia Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.6.6.5. Saudi Arabia Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.6.7. UAE
        • 10.6.7.1. UAE Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.6.7.2. UAE Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.6.7.3. UAE Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.6.7.4. UAE Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.6.7.5. UAE Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.6.8. Qatar
        • 10.6.8.1. Qatar Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.6.8.2. Qatar Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.6.8.3. Qatar Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.6.8.4. Qatar Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.6.8.5. Qatar Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.6.9. South Africa
        • 10.6.9.1. South Africa Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.6.9.2. South Africa Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.6.9.3. South Africa Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.6.9.4. South Africa Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.6.9.5. South Africa Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
      • 10.6.10. Rest of Middle East and Africa
        • 10.6.10.1. Rest of Middle East & Africa Veterinary Molecular Diagnostics market revenue, by product, 2017 - 2024 (USD Million)
        • 10.6.10.2. Rest of Middle East & Africa Veterinary Molecular Diagnostics market revenue, by technology, 2017 - 2024 (USD Million)
        • 10.6.10.3. Rest of Middle East & Africa Veterinary Molecular Diagnostics market revenue, by animal type, 2017 - 2024 (USD Million)
        • 10.6.10.4. Rest of Middle East & Africa Veterinary Molecular Diagnostics market revenue, by disease indication, 2017 - 2024 (USD Million)
        • 10.6.10.5. Rest of Middle East & Africa Veterinary Molecular Diagnostics market revenue, by end user, 2017 - 2024 (USD Million)
  •  
  • Chapter 11. Company Profile
    • 11.1. IDEXX Laboratories, Inc.
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Therapy portfolio
      • 11.1.4. Business strategy
      • 11.1.5. Recent developments
    • 11.2. ABAXIS, Inc.
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Therapy portfolio
      • 11.2.4. Business strategy
      • 11.2.5. Recent developments
    • 11.3. VCA, Inc.
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Therapy portfolio
      • 11.3.4. Business strategy
      • 11.3.5. Recent developments
    • 11.4. Neogen Corporation
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Therapy portfolio
      • 11.4.4. Business strategy
      • 11.4.5. Recent developments
    • 11.5. Thermo Fisher Scientific, Inc.
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Therapy portfolio
      • 11.5.4. Business strategy
      • 11.5.5. Recent developments
    • 11.6. Zoetis, Inc.
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Therapy portfolio
      • 11.6.4. Business strategy
      • 11.6.5. Recent developments
    • 11.7. GE Healthcare
      • 11.7.1. Overview
      • 11.7.2. Financials
      • 11.7.3. Therapy portfolio
      • 11.7.4. Business strategy
      • 11.7.5. Recent developments
    • 11.8. Heska Corporation
      • 11.8.1. Overview
      • 11.8.2. Financials
      • 11.8.3. Therapy portfolio
      • 11.8.4. Business strategy
      • 11.8.5. Recent developments
    • 11.9. ID.Vet
      • 11.9.1. Overview
      • 11.9.2. Financials
      • 11.9.3. Therapy portfolio
      • 11.9.4. Business strategy
      • 11.9.5. Recent developments
    • 11.10. Virbac
      • 11.10.1. Overview
      • 11.10.2. Financials
      • 11.10.3. Therapy portfolio
      • 11.10.4. Business strategy
      • 11.10.5. Recent developments
    • 11.11. Veterinary Molecular Diagnostics Inc.
      • 11.11.1. Overview
      • 11.11.2. Financials
      • 11.11.3. Therapy portfolio
      • 11.11.4. Business strategy
      • 11.11.5. Recent developments
    • 11.12. AGFA Healthcare
      • 11.12.1. Overview
      • 11.12.2. Financials
      • 11.12.3. Therapy portfolio
      • 11.12.4. Business strategy
      • 11.12.5. Recent developments

Methodology

Free Analysis

Molecular diagnostics is the set of techniques used to identify specific sequences in DNA or RNA that could be linked to diseases. Molecular diagnostics techniques help in subclassifying the disease and monitoring response of the treatment. Single Nucleotide Polymorphism (SNP), deletions, insertions, and rearrangements can be identified through molecular diagnostics techniques. Molecular diagnostics helps in developing personalized medicine as it makes it possible to analyze the specifics of patients and their disease. Molecular diagnostics is used in a variety of medical conditions like oncology, genetic disease screening, infectious disease, coagulation, and pharmacogenomics. Molecular diagnostics combines molecular genetics technology and knowledge of genomics.

Over the years, the study of genome has become an important part of medicine and human as well as veterinary health. The discovery of Polymerase Chain Reaction (PCR) played an important part in the widespread adoption of veterinary molecular diagnostics. Extensive research in genetics has given a boost to veterinary molecular diagnostics. Some of the most used veterinary molecular diagnostics techniques include Restriction Fragment Length Polymorphism (RFLP), Allele-Specific Oligonucleotide (ASO) Hybridization, Amplification Refractory Mutation System (ARMS), Oligonucleotide Ligation Assay (OLA), and Pyrosequencing, among others. Polymerase Chain Reaction (PCR) is most commonly used to detect a wide range of viral diseases in animals. Molecular assays are performed for livestock animals for detection and interpretation of diseases.

Veterinary molecular diagnostic techniques are rapidly gaining popularity over traditional testing methods. Polymerase Chain Reaction (PCR), a popular molecular diagnostic technique, is now routinely used in veterinary laboratories. Veterinary molecular diagnostics are extremely crucial during disease outbreaks, as it involves screening of a large number of samples in a short time. According to the European Food Safety Authority (EFSA), around 320,000 cases of foodborne and zoonotic diseases are reported every year. Applying veterinary molecular diagnostic techniques can pave the way for early detection and containment of disease outbreaks in animals.

Global Veterinary Molecular Diagnostics Market

The emergence of advanced veterinary molecular diagnostic tools over traditional diagnostic tools and a growing focus on adopted pet’s and livestock’s health and nutrition will drive the growth of veterinary molecular diagnostics market. However, the high costs associated with these techniques could restrict veterinary molecular diagnostics market growth.

Based on technology, the veterinary molecular diagnostics market has been segmented into microarrays, polymerase chain reaction (PCR), and DNA sequencing. On the basis of animal type, the market for veterinary molecular diagnostics is segmented into livestock animals and companion animals. Based on disease indication, the veterinary molecular diagnostics market is segmented into diarrhea pathogens detection, vector-borne diseases, respiratory pathogens detection, and others. Segmentation based on products for veterinary molecular diagnostics includes kits & reagents, instruments & software, and services. The end-user segment for veterinary molecular diagnostics is divided into research institutes, clinical laboratories, and veterinary hospitals.

North America is expected to remain the dominant region over the forecast period for veterinary molecular diagnostics market. Owing to the increasing adoption of companion animals, more people are willing to pay for veterinary care thus the demand for developing new treatment options is growing. All these factors will boost the market in this region. Europe anticipates being the second most dominant marketplace for veterinary molecular diagnostics market due to the presence of advanced livestock industry. The Asia Pacific is expected to grow at the fastest rate driven by high livestock population in India and China.

Some of the key players in veterinary molecular diagnostics are IDEXX Laboratories, Inc., ABAXIS, Inc., VCA, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Zoetis, Inc., GE Healthcare, Heska Corporation, ID.Vet, Virbac, Veterinary Molecular Diagnostics, Inc., and AGFA Healthcare.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com